Deal Spree Continues as Celgene Nabs Juno in $9B Deal Post author:Sam Post published:January 21, 2018 Post category:BioPharma The announcement sent shares of Juno soaring more than 27 percent in pre-market trading to $86.26. Source: BioSpace You Might Also Like How Gilead Just Lost $9 Billion in Market Value This Week February 8, 2017 FDA Calls Bay Area Global Blood Therapeutics' Sickle Cell Drug a Breakthrough January 8, 2018 University at Albany Release: Biochemist's Technique Rapidly Detects Ebola Virus February 16, 2017